DURECT CORPORATION (DRRX) Fundamental Analysis & Valuation

NASDAQ:DRRX • US2666055007

Current stock price

1.91 USD
-0.02 (-1.04%)
At close:
1.94 USD
+0.03 (+1.57%)
After Hours:

This DRRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DRRX Profitability Analysis

1.1 Basic Checks

  • In the past year DRRX has reported negative net income.
  • DRRX had a negative operating cash flow in the past year.
  • DRRX had negative earnings in each of the past 5 years.
  • DRRX had a negative operating cash flow in each of the past 5 years.
DRRX Yearly Net Income VS EBIT VS OCF VS FCFDRRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

  • DRRX's Return On Assets of -27.86% is in line compared to the rest of the industry. DRRX outperforms 54.31% of its industry peers.
  • DRRX has a Return On Equity (-99.86%) which is in line with its industry peers.
Industry RankSector Rank
ROA -27.86%
ROE -99.86%
ROIC N/A
ROA(3y)-55.09%
ROA(5y)-41.09%
ROE(3y)-139.78%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
DRRX Yearly ROA, ROE, ROICDRRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

  • DRRX's Gross Margin of 62.60% is fine compared to the rest of the industry. DRRX outperforms 70.56% of its industry peers.
  • In the last couple of years the Gross Margin of DRRX has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for DRRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.8%
GM growth 5Y0.25%
DRRX Yearly Profit, Operating, Gross MarginsDRRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DRRX Health Analysis

2.1 Basic Checks

  • DRRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DRRX has more shares outstanding
  • Compared to 5 years ago, DRRX has more shares outstanding
  • DRRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DRRX Yearly Shares OutstandingDRRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRRX Yearly Total Debt VS Total AssetsDRRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • DRRX has an Altman-Z score of -67.96. This is a bad value and indicates that DRRX is not financially healthy and even has some risk of bankruptcy.
  • DRRX has a Altman-Z score of -67.96. This is amonst the worse of the industry: DRRX underperforms 92.39% of its industry peers.
  • DRRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -67.96
ROIC/WACCN/A
WACC10.88%
DRRX Yearly LT Debt VS Equity VS FCFDRRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 0.98 indicates that DRRX may have some problems paying its short term obligations.
  • The Current ratio of DRRX (0.98) is worse than 80.71% of its industry peers.
  • DRRX has a Quick Ratio of 0.98. This is a bad value and indicates that DRRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DRRX has a Quick ratio of 0.95. This is in the lower half of the industry: DRRX underperforms 74.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.95
DRRX Yearly Current Assets VS Current LiabilitesDRRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DRRX Growth Analysis

3.1 Past

  • DRRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.61%, which is quite impressive.
  • Looking at the last year, DRRX shows a very negative growth in Revenue. The Revenue has decreased by -62.89% in the last year.
  • The Revenue for DRRX have been decreasing by -39.51% on average. This is quite bad
EPS 1Y (TTM)83.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
Revenue 1Y (TTM)-62.89%
Revenue growth 3Y-47.43%
Revenue growth 5Y-39.51%
Sales Q2Q%-79.41%

3.2 Future

  • Based on estimates for the next years, DRRX will show a very strong growth in Earnings Per Share. The EPS will grow by 60.95% on average per year.
  • The Revenue is expected to grow by 53.91% on average over the next years. This is a very strong growth
EPS Next Y-105.89%
EPS Next 2Y-24.45%
EPS Next 3Y57.26%
EPS Next 5Y60.95%
Revenue Next Year-92.31%
Revenue Next 2Y-22.88%
Revenue Next 3Y45.1%
Revenue Next 5Y53.91%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DRRX Yearly Revenue VS EstimatesDRRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
DRRX Yearly EPS VS EstimatesDRRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. DRRX Valuation Analysis

4.1 Price/Earnings Ratio

  • DRRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DRRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRRX Price Earnings VS Forward Price EarningsDRRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRRX Per share dataDRRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • DRRX's earnings are expected to grow with 57.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.45%
EPS Next 3Y57.26%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DRRX Dividend Analysis

5.1 Amount

  • DRRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DRRX Fundamentals: All Metrics, Ratios and Statistics

DURECT CORPORATION

NASDAQ:DRRX (9/10/2025, 8:00:01 PM)

After market: 1.94 +0.03 (+1.57%)

1.91

-0.02 (-1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-12
Earnings (Next)11-11
Inst Owners22.34%
Inst Owner Change-100%
Ins Owners11.82%
Ins Owner Change0%
Market Cap59.31M
Revenue(TTM)3.12M
Net Income(TTM)-3.48M
Analysts45.71
Price Target2.55 (33.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.78%
Min EPS beat(2)-9.24%
Max EPS beat(2)42.81%
EPS beat(4)3
Avg EPS beat(4)391.47%
Min EPS beat(4)-9.24%
Max EPS beat(4)1511.48%
EPS beat(8)6
Avg EPS beat(8)215.39%
EPS beat(12)10
Avg EPS beat(12)147.91%
EPS beat(16)13
Avg EPS beat(16)114.43%
Revenue beat(2)2
Avg Revenue beat(2)24.63%
Min Revenue beat(2)7.9%
Max Revenue beat(2)41.37%
Revenue beat(4)2
Avg Revenue beat(4)-9.47%
Min Revenue beat(4)-82.8%
Max Revenue beat(4)41.37%
Revenue beat(8)3
Avg Revenue beat(8)-13.96%
Revenue beat(12)3
Avg Revenue beat(12)-15.73%
Revenue beat(16)5
Avg Revenue beat(16)-0.21%
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.43%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)50%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19.01
P/FCF N/A
P/OCF N/A
P/B 17.03
P/tB 78.24
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.1
BVpS0.11
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -27.86%
ROE -99.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.6%
FCFM N/A
ROA(3y)-55.09%
ROA(5y)-41.09%
ROE(3y)-139.78%
ROE(5y)-96.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.8%
GM growth 5Y0.25%
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.65%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.95
Altman-Z -67.96
F-Score3
WACC10.88%
ROIC/WACCN/A
Cap/Depr(3y)86.47%
Cap/Depr(5y)78.99%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.67%
EPS Next Y-105.89%
EPS Next 2Y-24.45%
EPS Next 3Y57.26%
EPS Next 5Y60.95%
Revenue 1Y (TTM)-62.89%
Revenue growth 3Y-47.43%
Revenue growth 5Y-39.51%
Sales Q2Q%-79.41%
Revenue Next Year-92.31%
Revenue Next 2Y-22.88%
Revenue Next 3Y45.1%
Revenue Next 5Y53.91%
EBIT growth 1Y32.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-229.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.28%
OCF growth 3YN/A
OCF growth 5YN/A

DURECT CORPORATION / DRRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DURECT CORPORATION (DRRX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DRRX.


What is the valuation status for DRRX stock?

ChartMill assigns a valuation rating of 1 / 10 to DURECT CORPORATION (DRRX). This can be considered as Overvalued.


How profitable is DURECT CORPORATION (DRRX) stock?

DURECT CORPORATION (DRRX) has a profitability rating of 1 / 10.


What is the financial health of DURECT CORPORATION (DRRX) stock?

The financial health rating of DURECT CORPORATION (DRRX) is 4 / 10.